Tammy M. Havener

Genetic Variants in <i>CPA6</i> and <i>PRPF31</i> Are Associated With Variation in Response to Metformin in Individuals With Type 2 Diabetes

Daniel M. Rotroff, Sook Wah Yee, Kaixin Zhou et al. · Diabetes · 2018 · 54 citations · Full text

Pharmacogenomic Characterization of US FDA-approved Cytotoxic Drugs

Eric Peters, Alison A. Motsinger‐Reif, Tammy M. Havener et al. · Pharmacogenomics · 2011 · 46 citations · Full text

Design of a Cyclin G Associated Kinase (GAK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Set to Interrogate the Relationship of EGFR and GAK in Chordoma

Christopher R. M. Asquith, Kaleb M. Naegeli, Michael P. East et al. · Journal of Medicinal Chemistry · 2019 · 41 citations · Full text

Tumor Biology, Gak Inhibition, Medicine +12

Synergistic drug combinations and machine learning for drug repurposing in chordoma

Edward Anderson, Tammy M. Havener, Kimberley M. Zorn et al. · Scientific Reports · 2020 · 41 citations · Full text

Genetic Variants in <i>HSD17B3</i>, <i>SMAD3</i>, and <i>IPO11</i> Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes

Daniel M. Rotroff, Sonja S. Pijut, Skylar W. Marvel et al. · Clinical Pharmacology & Therapeutics · 2017 · 37 citations · Full text